Editorial by Prof Nikolaos Papanikolaou, Scientific manager of the ProCAncer-I project ProCAncer-I is a collaborative project that combines the efforts of 20 clinical and technical partners in Europe and US. The focus is to collect the biggest in size, diverse dataset...
Newsletter #3
UC2: Characterization of cancer according to its biological aggressiveness
Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute Patients diagnosed with localised prostate cancer (PCa) are classified in different risk groups, i.e. low, intermediate or high risk, and this choice will affect treatment and...
The Annotation tool
by Quibim Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail. The company has developed AI algorithms for...
Curating the data curation tool
by Advantis Medical Imaging Curating datasets is not an easy task. On the contrary, it can bring about hard-to-solve problems and lead to open-ended discussions, until a satisfactory solution is found. In ProCAncer-I, the curation of medical images has been a...
The largest collection of PCa multi-parametric anonymized image data worldwide
Interview with Prof Luis Martí-Bonmatí. Director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital and Head of Radiology Department at QuironSalud Hospital in Valencia In ProCAncer-I you advertise that the platform that...
Advisory Board
Prof. Vincenzo Valentini is Professor of Radiation Oncology at the Faculty of Medicine of the Università Cattolica S.Cuore in Rome and Director of the Department of Radiology, Radiation Oncology and Haematology at the Policlinico Universitario A.Gemelli-IRCCS in Rome....
Presentation of partner QUIBIM, QUantitative Imaging Biomarkers In Medicine
Quibim is the go-to imaging partner bringing virtual biopsies to diagnostics and drug discovery. By following an AI-first approach to help detect pathologies and predict outcomes in oncology/immunotherapy, rheumatology and neurology. The company is specialized in...
Presentation of partner University of Pisa – The Imaging Lab
The University of Pisa is an Italian public research university located in Pisa, Italy. It was founded in 1343 by an edict of Pope Clement VI. It is the 19th oldest extant university in the world and the 10th oldest in Italy. The university is ranked within the top 10...
Presentation of partner Hacettepe University – Department of Radiology
The Radiology Department of the Hacettepe University is located in Ankara, Turkey. With decades of experience, all radiologic imaging procedures as well as interventional radiology services in scope of modern medicine are performed by the experienced and specialized...
Newsletter #3 Contents
Highlights
ProCAncer-I at the ECR 2025 in Vienna
Jan 16, 2025
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
ProCAncer-I at the Healthcare Business Awards 2024
Dec 19, 2024
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the first EIT Health Morning Talks in Bosnia and Herzegovina
Dec 3, 2024
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
ProCAncer-I at the EMUC24 in Lisbon
Oct 1, 2024
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices were discussed at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24). The congress took place from the 7th to 10th of November 2024...